| Spirig HealthCare AG - Pazopanib Spirig HC 200 mg, Filmtabletten | | 69276 | | 01 | | Pazopanib Spirig HC 200 mg | | Filmtabletten | | L01EX03 | | Pazopanib | | 06.10.2023 | | |
| | Composition | | pazopanibum 200 mg ut pazopanibi hydrochloridum, cellulosum microcristallinum, carboxymethylamylum natricum A, povidonum K 30, magnesii stearas, Überzug: hypromellosum, E 171, macrogolum 400, E 172 (rubrum), polysorbatum 80, pro compresso obducto corresp. natrium max. 1.10 mg. | | Packungsbestandteile | | Comprimés filmés | | | | | Principe actif | Concentr. |
|---|
| Pazopanibum | 200 mg |
| | BAG: Principe actif | Concentr. |
|---|
| Pazopanibum | 200 mg |
| | | | Agents auxilliaires | Concentr. | informations additionels |
|---|
| (Rubrum) | | | | Carboxymethylamylum Natricum A | | | | Cellulosum Microcristallinum | | | | E 171 | | color. | | E 172 | | color. | | Hypromellosum | | Überzug | | Macrogol | 400 | | | Magnesii Stearas | | | | Polysorbatum 80 | | | | Povidonum K | 30 | | | Pro Compresso Obducto | | |
| |
| | numéro d'emballage | Taille des présentations | PEF | PP | Cat. | LS | Hors commerce (MedRef) |
|---|
| 001 | 30 | 486.42 | 545.45 | A | LS | Non |
|
|
